172 related articles for article (PubMed ID: 36898947)
21. Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition.
Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
Hum Pathol; 2019 Dec; 94():16-22. PubMed ID: 31666197
[TBL] [Abstract][Full Text] [Related]
22. Updates in Staging and Reporting of Testicular Cancer.
Magers MJ; Idrees MT
Surg Pathol Clin; 2018 Dec; 11(4):813-824. PubMed ID: 30447843
[TBL] [Abstract][Full Text] [Related]
23. Testicular cancer: risk stratification in adolescents with nonseminoma.
Looijenga LH
Nat Rev Urol; 2014 Jul; 11(7):367-8. PubMed ID: 24960597
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
25. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
26. Pagetoid spread into the rete testis by testicular tumours.
Lee AH; Theaker JM
Histopathology; 1994 Apr; 24(4):385-9. PubMed ID: 8045529
[TBL] [Abstract][Full Text] [Related]
27. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
28. Mixed germ cell testicular tumor presenting as metastatic cutaneous choriocarcinoma.
Bonilla L; Harris A; McGarry K; Dyer RK; Telang G; Robinson-Bostom L
J Am Acad Dermatol; 2011 Aug; 65(2):455-456. PubMed ID: 21763587
[No Abstract] [Full Text] [Related]
29. [Treatment strategy for stage I testicular germ cell tumor].
Nakai Y; Nagahara A; Uemura M; Takayama H; Nonomura N
Hinyokika Kiyo; 2012 Dec; 58(12):715-20. PubMed ID: 23328172
[TBL] [Abstract][Full Text] [Related]
30. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
[TBL] [Abstract][Full Text] [Related]
31. What Is the Significance of Rete Testis Invasion by Malign Germ Cell Tumor and Does Hilum Predict Metastasis?
Ediz C; Ihvan A
Urol Int; 2019; 103(1):49-54. PubMed ID: 31203276
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of clinical staging and efficacy of treatment in non-seminomatous germ-cell tumours of the testis.
de Kock ML; Allen FJ; Breytenbach IH; van der Merwe AM
S Afr J Surg; 1987 Sep; 25(3):87-9. PubMed ID: 2825363
[No Abstract] [Full Text] [Related]
33. [Stage-specific treatment for testicular germ cell tumours].
Heidenreich A; Bokemeyer C; Souchon R
Urologe A; 2009 Apr; 48(4):377-85. PubMed ID: 19252891
[TBL] [Abstract][Full Text] [Related]
34. Treatment options for stage I nonseminoma.
Feldman DR
J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
[No Abstract] [Full Text] [Related]
35. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
[TBL] [Abstract][Full Text] [Related]
36. Management of clinical stage I nonseminomatous germ-cell testis tumors.
Flechon A; Droz JP
Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
[TBL] [Abstract][Full Text] [Related]
37. Nonseminomatous testicular cancer.
Freiha F
J Med Liban; 2005; 53(2):91-4. PubMed ID: 16604994
[TBL] [Abstract][Full Text] [Related]
38. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
[TBL] [Abstract][Full Text] [Related]
39. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
40. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]